首页 | 本学科首页   官方微博 | 高级检索  
检索        

艰难梭菌感染的诊断及治疗研究进展
引用本文:季欣欣,孟秀娟,任南,黄勇.艰难梭菌感染的诊断及治疗研究进展[J].中国感染控制杂志,2019,18(6):600-606.
作者姓名:季欣欣  孟秀娟  任南  黄勇
作者单位:艰难梭菌感染的诊断及治疗研究进展
基金项目:国家自然科学基金面上项目(81473123)
摘    要:艰难梭菌是一种革兰阳性厌氧芽孢杆菌,现已成为全球分布的主要肠道病原体。艰难梭菌感染(Clostridium difficile infection,CDI)可引起抗菌药物相关性腹泻,而其严重感染会导致假膜性结肠炎和中毒性巨结肠等严重并发症。CDI正成为全世界公共卫生的一个持续挑战。本文就近年来国内外CDI的诊断、预防和治疗予以简要综述,为防治CDI提供依据。

关 键 词:艰难梭菌  毒素  感染  危险因素  肠道菌群  
收稿时间:2019-04-25

Advances in diagnosis and treatment of Clostridium difficile infection
JI Xin-xin,MENG Xiu-juan,REN Nan,HUANG Yong.Advances in diagnosis and treatment of Clostridium difficile infection[J].Chinese Journal of Infection Control,2019,18(6):600-606.
Authors:JI Xin-xin  MENG Xiu-juan  REN Nan  HUANG Yong
Institution:1. Xiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China;2. Center for Healthcare-associated Infection Control, Xiangya Hospital, Central South University, Changsha 410008, China;3. National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery, Changsha 410205, China
Abstract:Clostridium difficile (C. difficile) is a gram-positive anaerobic bacillus and has become a major intestinal pathogen worldwide. C. difficile infection (CDI) can cause antimicrobial-associated diarrhea, severe infection may lead to severe complications such as pseudomembranous colitis and toxic megacolon. CDI is becoming a continuing challenge to public health worldwide. In this paper, the diagnosis, prevention and treatment of CDI at home and abroad in recent years are briefly reviewed, so as to provide a basis for the prevention and treatment of CDI.
Keywords:Clostridium difficile  toxin  infection  risk factor  intestinal flora  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号